Home » Topics » BioWorld Science

BioWorld Science
RSS

Qinlock approved in China for advanced GIST

April 1, 2021

Primary safety endpoint met in phase Ib/II study of BXCL-501 to treat opioid withdrawal symptoms

April 1, 2021

COMMD1 as therapeutic target and diagnostic biomarker in NSCLC

April 1, 2021

Sichuan Kelun-Biotech Biopharmaceutical patents nuclear receptor ROR-gamma agonists

April 1, 2021

New Nur77 receptor ligands disclosed by Ixmedicine

April 1, 2021

IMPACT Therapeutics identifies new ATM kinase inhibitors

April 1, 2021

Amgen describes new IL-22 compositions

April 1, 2021

5-HT4 receptor agonists discovered at Sunshine Lake Pharma

April 1, 2021

First patient dosed in registrational phase I/II study of GC-007G

April 1, 2021

Topline data from phase IIb portion of the phase IIb/III COVID-19 trial of ifenprodil

April 1, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...